Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROCEPT BioRobotics Corp
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,791 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 3,315 · Balance 8,791 F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.78 · Expires 2036-06-08 | Direct | 5,853 |
Reported balance
After 2026-06-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-09 · Grant · Acquired 5,853 · Balance 5,853 F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Shockwave Medical, Inc.
Report date February 05, 2024 · Filed February 07, 2024
Section 16 reporting ended · disclosed 2024-02-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,005 |
Ending reported balance
After 2024-02-05 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2024-02-05 · Tax withholding · Disposed 2,208 · Balance 25,524 Row 2 · 2024-02-05 · Tax withholding · Disposed 1,077 · Balance 24,447 Row 3 · 2024-02-05 · Tax withholding · Disposed 213 · Balance 24,234 Row 4 · 2024-02-05 · Sale · Disposed 300 · Balance 23,934 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Row 5 · 2024-02-05 · Sale · Disposed 1,703 · Balance 22,231 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F3: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Row 6 · 2024-02-05 · Sale · Disposed 1,226 · Balance 21,005 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F4: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
Filing footnotes · ownership attribution and instrument terms
F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023.
F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 19, 2021 Filed Apr 20, 2021 01:53 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 683 | $3.42 | $2,335.86 |
DisclosureSEC source: 0000950103-21-005729 · dp149579_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 01:53 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,109 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-21-005729 · dp149579_4-puckett.xml · derivative · entry 13 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,915 Underlying: Common Stock · 1,109 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F11 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 3/11/19. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 01:53 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 100 | $140.14 | $14,014.00 |
DisclosureSEC source: 0000950103-21-005729 · dp149579_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,788 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $140.14 to $140.14. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 01:53 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 300 | $139.30 | $41,790.00 |
DisclosureSEC source: 0000950103-21-005729 · dp149579_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,888 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $139.1318 to $139.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 01:53 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 583 | $138.56 | $80,780.48 |
DisclosureSEC source: 0000950103-21-005729 · dp149579_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,188 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $138.05 to $139.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 01:53 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 126 | $136.89 | $17,248.14 |
DisclosureSEC source: 0000950103-21-005729 · dp149579_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,771 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $136.73 to $137.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 01:53 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,109 | $17.00 | $18,853.00 |
DisclosureSEC source: 0000950103-21-005729 · dp149579_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:58 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-21-005225 · dp149076_4-puckett.xml · derivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,024 Underlying: Common Stock · 5,000 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 3/11/19. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:58 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 422 | $132.98 | $56,117.56 |
DisclosureSEC source: 0000950103-21-005225 · dp149076_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,788 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $132.75 to $133.46. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:58 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 3,348 | $131.49 | $440,228.52 |
DisclosureSEC source: 0000950103-21-005225 · dp149076_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,210 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $131.18 to $132.16. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:58 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 3,524 | $130.83 | $461,044.92 |
DisclosureSEC source: 0000950103-21-005225 · dp149076_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,558 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $130.18 to $131.15. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:58 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,807 | $129.64 | $234,259.48 |
DisclosureSEC source: 0000950103-21-005225 · dp149076_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,082 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $129.17 to $130.14. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:58 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,399 | $128.76 | $180,135.24 |
DisclosureSEC source: 0000950103-21-005225 · dp149076_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,889 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $128.16 to $129.11. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:58 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 5,000 | $17.00 | $85,000.00 |
DisclosureSEC source: 0000950103-21-005225 · dp149076_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 02:05 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,658 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-21-003463 · dp147295_4-puckett.xml · derivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,024 Underlying: Common Stock · 1,658 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 3/11/19. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 02:05 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 342 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0000950103-21-003463 · dp147295_4-puckett.xml · derivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 342 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/21/17. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 02:05 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,000 | $123.92 | $123,920.00 |
DisclosureSEC source: 0000950103-21-003463 · dp147295_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,228 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $123.51 to $124.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 02:05 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 600 | $122.71 | $73,626.00 |
DisclosureSEC source: 0000950103-21-003463 · dp147295_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,228 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $122.28 to $123.10. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 02:05 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $121.16 | $24,232.00 |
DisclosureSEC source: 0000950103-21-003463 · dp147295_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,828 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $121.03 to $121.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 02:05 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $120.21 | $24,042.00 |
DisclosureSEC source: 0000950103-21-003463 · dp147295_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,028 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $119.79 to $120.62. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 02:05 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,658 | $17.00 | $28,186.00 |
DisclosureSEC source: 0000950103-21-003463 · dp147295_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 02:05 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 342 | $3.42 | $1,168.27 |
DisclosureSEC source: 0000950103-21-003463 · dp147295_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 02:10 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Tax withholdingCommon Stock | 3,080 | $123.19 | $379,425.20 |
DisclosureSEC source: 0000950103-21-002608 · dp146442_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,228 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:35 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,659 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-21-001678 · dp145561_4-puckett.xml · derivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,682 Underlying: Common Stock · 1,659 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 3/11/19. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:35 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 341 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0000950103-21-001678 · dp145561_4-puckett.xml · derivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,023 Underlying: Common Stock · 341 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/21/17. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:35 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 101 | $118.66 | $11,984.66 |
DisclosureSEC source: 0000950103-21-001678 · dp145561_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $118.59 to $118.66. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:35 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,288 | $117.97 | $151,945.36 |
DisclosureSEC source: 0000950103-21-001678 · dp145561_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,409 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $117.46 to $118.37. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:35 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 611 | $116.91 | $71,432.01 |
DisclosureSEC source: 0000950103-21-001678 · dp145561_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,697 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $116.44 to $117.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:35 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,659 | $17.00 | $28,203.00 |
DisclosureSEC source: 0000950103-21-001678 · dp145561_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:35 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 341 | $3.42 | $1,164.86 |
DisclosureSEC source: 0000950103-21-001678 · dp145561_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| February 01, 2021 Filed Feb 9, 2021 00:56 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-001970 · dp145833_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,308 Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:01 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,658 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-21-000169 · dp142360_4-puckett.xml · derivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,341 Underlying: Common Stock · 1,658 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 3/11/19. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:01 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 342 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0000950103-21-000169 · dp142360_4-puckett.xml · derivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,364 Underlying: Common Stock · 342 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/21/17. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:01 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 141 | $103.47 | $14,589.27 |
DisclosureSEC source: 0000950103-21-000169 · dp142360_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $103.36 to $103.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:01 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 938 | $102.82 | $96,445.16 |
DisclosureSEC source: 0000950103-21-000169 · dp142360_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,449 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $102.35 to $103.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:01 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 921 | $101.70 | $93,665.70 |
DisclosureSEC source: 0000950103-21-000169 · dp142360_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,387 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $101.24 to $102.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:01 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,658 | $17.00 | $28,186.00 |
DisclosureSEC source: 0000950103-21-000169 · dp142360_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:01 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 342 | $3.42 | $1,168.27 |
DisclosureSEC source: 0000950103-21-000169 · dp142360_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,659 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-20-023758 · dp142360_4-puckett.xml · derivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,999 Underlying: Common Stock · 1,659 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 3/11/19. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 341 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0000950103-20-023758 · dp142360_4-puckett.xml · derivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,706 Underlying: Common Stock · 341 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/21/17. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $96.43 | $19,286.00 |
DisclosureSEC source: 0000950103-20-023758 · dp142360_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $96.30 to $96.55. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $95.41 | $19,082.00 |
DisclosureSEC source: 0000950103-20-023758 · dp142360_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,508 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $95.27 to $95.55. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 900 | $94.59 | $85,131.00 |
DisclosureSEC source: 0000950103-20-023758 · dp142360_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,708 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $94.15 to $95.04. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 700 | $93.17 | $65,219.00 |
DisclosureSEC source: 0000950103-20-023758 · dp142360_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,608 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $92.90 to $93.69. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,659 | $17.00 | $28,203.00 |
DisclosureSEC source: 0000950103-20-023758 · dp142360_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 341 | $3.42 | $1,164.86 |
DisclosureSEC source: 0000950103-20-023758 · dp142360_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 01:15 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,336 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0000950103-20-022100 · dp140819_4-puckett.xml · derivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,774 Underlying: Common Stock · 1,336 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/19/18. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 01:15 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,295 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0000950103-20-022100 · dp140819_4-puckett.xml · derivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,047 Underlying: Common Stock · 3,295 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/21/17. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 01:15 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,369 | $0.00 Strike: $2.92 | $0.00 |
DisclosureSEC source: 0000950103-20-022100 · dp140819_4-puckett.xml · derivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,369 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vested on 4/15/17 and the balance of the shares shall vest in equal monthly installments thereafter for 36 months. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 01:15 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 10,000 | $84.75 | $847,500.00 |
DisclosureSEC source: 0000950103-20-022100 · dp140819_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $84.50 to $85.10. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.